KEY TAKEAWAYS
- Q1 FY2027 net sales: $112.6M, up 32.3% YoY, well above the 15-20% growth guided in June. Adjusted EBITDA: $13.8M, up 86% YoY. EPS: $0.06, reversing from a -$0.08 loss a year ago. New products represented 35% of shipments.
- SWBI unit shipments rose nearly 20% vs adjusted NICS background of 7.7% — implying roughly 12 percentage points of market share gains. Handgun shipments up 17% vs category NICS up 5%. Channel inventory for long guns declined 5,000 units, confirming strong retail sell-through.
- Full-year FY2027 revenue guidance held at 5-7% growth, and Q2 guided at roughly 10% above last year — implying H2 is likely roughly flat to down YoY to reconcile a 32% Q1 with a 5-7% full year. Capital expenditures: $45-50M, approximately $25M above the historical run rate, for Springfield facility investments.
Smith & Wesson Brands, Inc. (NASDAQ: SWBI) makes firearms — handguns, modern sporting rifles, and lever-action rifles — sold through sporting goods retailers and distributors across the United States. Q1 fiscal 2027 produced 32% revenue growth and a return to profitability. The full-year guidance implies growth of 5% to 7%. Those two facts together contain the most interesting analytical question in this earnings report: what happens in the second half?
What they reported
Net sales of $112.6 million, up 32.3% year-over-year. Gross margin of 28.7%, including $2.9 million in tariff refunds; excluding refunds, gross margin was approximately 26.1%. Adjusted EBITDAS of $13.8 million, or 12.2% of net sales, up 86% from $7.4 million and 8.7% margin a year ago. GAAP EPS of $0.06, reversing from a loss of $0.08. Channel inventory for handguns remained flat sequentially, and long gun inventory declined by 5,000 units, both indicators of strong retail pull-through. Company inventory at $180.7 million, up from $156.3 million in Q4 as seasonal building for fall and winter occurred.
Beat or miss
Beat decisively. The 15-20% growth guidance from June turned into 32.3% actual. Management attributed the outperformance to stronger-than-expected demand across polymer pistols, modern sporting rifles, and lever-action rifles, combined with new product launches that drove higher average selling prices. Despite the significant Q1 beat, the company held full-year guidance at 5-7% growth, which is the math worth understanding.
The market share story — 20% growth vs 7.7% NICS
NICS — National Instant Criminal Background Check System — is the best publicly available proxy for US firearms retail demand. When someone buys a firearm at a licensed dealer, a NICS check is conducted. Adjusted NICS data, which filters out permit renewals and other non-sale checks, grew approximately 7.7% year-over-year in Q1. Smith & Wesson's unit shipments grew nearly 20%. That gap — 12 percentage points of outperformance versus the market — represents meaningful share gain against competitors. Handguns specifically: SWBI shipments up 17% versus category NICS up 5%. The 1854 Lever Action Rifle shipments doubled year-over-year as the company expanded into the hunting segment with a product that had been absent from the lineup.
The new product contribution of 35% of total shipments is the mechanism behind the market share gain. New products typically carry higher average selling prices, which improves revenue mix even at similar unit volumes. CEO Mark Smith described the Q1 as reflecting "brand strength paired with a purposeful long-term strategy" — the specific strategy being a disciplined cadence of new product introductions that keeps Smith & Wesson's lineup fresh and competitively positioned in a market where consumer product cycles move quickly.
The H2 deceleration math
Here's the arithmetic that the analyst community spent time on in Q&A. Q1 came in at 32% growth. Q2 is guided at roughly 10% above last year. The full year is guided at 5-7% growth. Simple math implies that H2 fiscal 2027 — the October 2026 through April 2027 period — needs to run at roughly flat to down year-over-year to reconcile a 32% Q1 and 10% Q2 with a 5-7% full year. That's a significant implied deceleration.
Management's explanation: last year's results were heavily weighted toward Q4 due to state-level regulatory changes driving elevated modern sporting rifle demand in certain markets. The comparison base in H2 of fiscal 2026 was unusually high, not an ordinary run rate. This year's growth is expected to be "steadier" across quarters — which means Q1's 32% was partly filling demand that didn't materialize last summer, and H2 this year competes against last year's inflated base. The distributor inventory decline of 6.8% in the quarter confirms that retail is pulling product through, which suggests the demand is genuine rather than channel-filling.
The Springfield facility — $25M above normal capex
Capital expenditures of $45 to $50 million for the full year, approximately $25 million above the historical run rate, are being invested in the Springfield, Tennessee manufacturing facility. Management described this as capacity and capability investment to support product expansion and efficiency improvements. The elevated capex compresses free cash flow in fiscal 2027 but is expected to reduce over the following years as the projects complete. For investors focused on cash returns, the capex headwind is worth modeling — SWBI's free cash flow profile looks different in FY2027 than in a normalized capex year.
The one thing beginners should take away
Smith & Wesson had one of the strongest Q1 results in recent company history — 32% revenue growth, 86% EBITDA growth, clear market share gains against the industry NICS backdrop. The company then guided for 5-7% full-year growth, implying H2 is going to look a lot quieter than Q1. That's not a contradiction — it's an honest description of a business with lumpy quarterly comparisons and a clear explanation for why H2 looks different from H1. The 1854 lever-action launch, the new polymer pistol lineup, and the 35% new product contribution rate all suggest a company with genuine product momentum. Whether the stock reflects that momentum appropriately depends on whether you believe the H2 comparison explanation or think the deceleration signals something more structural.